Description
The U.S. arthritis market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 10.2% in the forecast period of 2022 to 2029 and is expected to reach USD 78,400.47 million by 2029 from USD 36,046.73 million in 2021.
Moreover, the geriatric population is most susceptible to arthritis, which is expected to boost the growth of the market. However, the high cost associated with medication and therapy is expected to hamper the growth of the market.Various government initiatives to aid awareness and correct diagnosis of arthritis may boost the growth of the market.
U.S. Arthritis Market Analysis and Insights
The major factor that is expected to drive the growth of the U.S. arthritis market is rising patient awareness of arthritis treatment, which leads to increased adoption of diagnosis and treatment. The sedentary lifestyle tradition leading to reduced indulgence in physical activities is also a major factor. There is a substantial rise in obesity and unhealthy food habits which is expected to increase the demand for Arthritis drugs.
Arthritis is a disease that affects the joints. A complete cure for arthritis does not exist, but with existing medication, symptoms such as swelling, pain, and wearing down of joints due to this disease can be kept under closer check. Due to medications such as Disease-modifying antirheumatic drugs (DMARDs) and biological response modifiers, arthritis patients can have a better quality of life, free from constant pain, and difficulty in movement.
